Research Articles
Validating In Silico Lipophilicity Predictions: A Comprehensive Guide for Drug Discovery Scientists
Accurate prediction of lipophilicity, commonly measured as logP and logD, is crucial in drug discovery as it directly influences a compound's absorption, distribution, metabolism, and excretion (ADME).
Beyond Rule of Five: A Strategic Guide to Optimizing TPSA/MW Ratio for Oral Drug Candidates
This article provides a comprehensive guide for researchers and drug development professionals on optimizing the Topological Polar Surface Area to Molecular Weight (TPSA/MW) ratio for beyond Rule of Five (bRo5)...
Chromatographic vs Computational logP Determination: A Comprehensive Guide for Drug Development
Lipophilicity, quantified as logP, is a critical physicochemical parameter influencing the absorption, distribution, metabolism, and toxicity of drug candidates.
Navigating the Lipophilicity-Promiscuity Nexus: Strategies for Optimizing Drug Safety and Efficacy
This article provides a comprehensive analysis of the critical relationship between high lipophilicity and target promiscuity in small-molecule drug discovery.
Lipophilic Conjugates in Drug Development: Strategies to Enhance Pharmacokinetic Profiles and Therapeutic Efficacy
This article provides a comprehensive review of lipid-drug conjugates (LDCs) as a transformative strategy for optimizing the pharmacokinetic and therapeutic profiles of active pharmaceutical ingredients.
Balancing Lipophilicity and Polar Surface Area: A Strategic Framework for Optimizing Drug Bioavailability
This article provides a comprehensive guide for researchers and drug development professionals on the critical interplay between lipophilicity and polar surface area (PSA) in drug design.
Overcoming Metabolic Instability in Lipophilic Compounds: Strategies for Enhanced Bioavailability and Drug Development
This article addresses the critical challenge of metabolic instability in lipophilic compounds, a major obstacle in pharmaceutical development that limits oral bioavailability and therapeutic efficacy.
Strategic Halogen Addition in Drug Design: Optimizing Lipophilicity and Half-life for Enhanced Therapeutics
This article provides a comprehensive analysis of halogen incorporation as a strategic tool in medicinal chemistry for optimizing key drug properties.
Beyond Lipophilicity: Advanced Strategies to Reduce Unbound Clearance in Drug Development
Optimizing pharmacokinetics requires a nuanced approach to balancing unbound clearance (CLu) and lipophilicity, a challenge often oversimplified in drug design.
Overcoming Solubility Challenges in Lipophilic Compounds: Strategies for Enhanced Bioavailability in Drug Development
This article provides a comprehensive analysis of the strategies and technologies employed to overcome solubility challenges in lipophilic compounds, a critical hurdle affecting nearly 90% of drug candidates.